This section shares significant or recent information about the Global Fund (guidelines, new funding schemes and other relevant topics), as well as information about civil society and communities participation in national and regional responses to HIV and AIDS, tuberculosis and malaria.

Stop TB Partnership and Johnson & Johnson, with support fromUSAID and The Global Fund, Announce Price Reduction for bedaquiline for Treatment of DR-TB in Low- and Middle-Income Countries


Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic
In 2020,